Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) EBT (2016 - 2025)

AtriCure (ATRC) has disclosed EBT for 16 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 115.42% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.2 million, a 76.73% increase, with the full-year FY2025 number at -$10.2 million, up 76.73% from a year prior.
  • EBT was $2.4 million for Q4 2025 at AtriCure, up from -$86000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $97.1 million in Q3 2021 to a low of -$16.9 million in Q1 2021.
  • A 5-year average of -$4.0 million and a median of -$8.4 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: soared 2061.36% in 2021, then tumbled 132.55% in 2023.
  • AtriCure's EBT stood at -$13.7 million in 2021, then skyrocketed by 70.42% to -$4.0 million in 2022, then crashed by 132.55% to -$9.4 million in 2023, then tumbled by 62.51% to -$15.3 million in 2024, then skyrocketed by 115.42% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's EBT are $2.4 million (Q4 2025), -$86000.0 (Q3 2025), and -$5.9 million (Q2 2025).